Vireo Growth (VREOF) Cost of Revenue (2020 - 2026)

Vireo Growth's (VREOF) quarterly Cost of Revenue came in at $46.9 million in Q1 2026, up 287.6% year-on-year from $12.1 million in Q1 2025, and down 1.53% quarter-over-quarter from $47.6 million in Q4 2025.

Vireo Growth (VREOF) Cost of Revenue (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Cost of Revenue across 7 years of filings, most recently posting $46.9 million for Q1 2026.

  • Cost of Revenue for Q1 2026 came in at $46.9 million, up 287.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $176.4 million (up 608.58% YoY), and the FY2025 annual result was $141.7 million, up 191.43% from the prior year.
  • Cost of Revenue came in at $46.9 million for Q1 2026 at Vireo Growth, down from $47.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $54.3 million in Q3 2025 to a low of $161782.0 in Q3 2023.
  • The 5-year median for Cost of Revenue is $240322.0 (2022), against an average of $12.0 million.
  • Across the five-year window, Cost of Revenue slumped 96.3% in 2022 and jumped 22519.81% in 2025, its largest moves.
  • Vireo Growth's Cost of Revenue stood at $240322.0 in 2022, then declined by 25.93% to $178017.0 in 2023, then soared by 6849.53% to $12.4 million in 2024, then jumped by 284.99% to $47.6 million in 2025, then dropped by 1.53% to $46.9 million in 2026.
  • The last three Cost of Revenue figures came in at $46.9 million (Q1 2026), $47.6 million (Q4 2025), and $54.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 696.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 641.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 133.40 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 34.44 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 13.80 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 586.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 155.56 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 52.68 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 222.00 Mn
10 Vireo Growth - - 59.30 Mn 46.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 46.90 Mn
Mar 31, 2026 46.90 Mn
Dec 31, 2025 47.63 Mn
Dec 31, 2025 47.63 Mn
Sep 30, 2025 54.27 Mn
Sep 30, 2025 54.27 Mn
Jun 30, 2025 27.65 Mn
Jun 30, 2025 27.65 Mn
Mar 31, 2025 12.10 Mn
Mar 31, 2025 12.10 Mn
Dec 31, 2024 12.37 Mn
Dec 31, 2024 12.37 Mn
Sep 30, 2024 239,932.00
Sep 30, 2024 239,932.00
Jun 30, 2024 189,946.00
Jun 30, 2024 189,946.00
Mar 31, 2024 222,014.00
Mar 31, 2024 222,014.00
Dec 31, 2023 178,017.00
Dec 31, 2023 178,017.00